Standard tools don't help, study finds, but a specialized assessment does ...

A new risk stratification model for idiopathic pulmonary fibrosis could shift treatment from passive monitoring to active, goal-oriented care.

Please provide your email address to receive an email when new articles are posted on . Eight clusters of related biomarkers were significantly associated with RA-ILD. The biomarkers led to a greater ...

Rural ILD patients experience significant diagnostic and treatment delays compared to urban counterparts, highlighting access challenges. Telehealth shows promise in improving access to ILD care, ...

Relapse rates over 3 years did not differ with glucocorticoid withdrawal vs maintenance among patients with stable SjD-ILD.

The prevalence of interstitial lung disease (ILD) across connective tissue disorders (CTDs) and its persistent standing as a leading cause of death in patients with CTDs challenge rheumatologists to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Concurrent pulmonary arterial hypertension and ...

Treatment regimens of steroids and disease-modifying antirheumatic drugs were effective in reducing the short-term death rate among patients with acute exacerbation of interstitial lung disease ...

New-onset interstitial lung disease (ILD) in patients with systemic sclerosis (SSc) occurred at a rate of 3.83 cases per 100 person-years, with detection noted up to 10 years post-negative screening ...

Serac Healthcare has received fast track designation from the US Food and Drug Administration for 99mTc‑maraciclatide, a SPECT‑CT imaging agent intended for the visualisation of inflammation in ...